GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $650,000 | +2.2% | 14,848 | +1.7% | 0.16% | +25.2% |
| Q1 2022 | $636,000 | +18.7% | 14,596 | +20.2% | 0.13% | +7.6% |
| Q4 2021 | $536,000 | +70.7% | 12,145 | +48.0% | 0.12% | +59.5% |
| Q3 2021 | $314,000 | -7.1% | 8,206 | -3.4% | 0.07% | -7.5% |
| Q2 2021 | $338,000 | +1.2% | 8,496 | -9.1% | 0.08% | -9.1% |
| Q1 2021 | $334,000 | -4.6% | 9,348 | -1.8% | 0.09% | -11.1% |
| Q4 2020 | $350,000 | -20.3% | 9,522 | -18.3% | 0.10% | -32.7% |
| Q3 2020 | $439,000 | -19.9% | 11,657 | -13.2% | 0.15% | -18.3% |
| Q2 2020 | $548,000 | -2.8% | 13,428 | -9.8% | 0.18% | -25.6% |
| Q1 2020 | $564,000 | -27.2% | 14,887 | -11.6% | 0.24% | +14.2% |
| Q4 2019 | $775,000 | +18.3% | 16,840 | +9.6% | 0.21% | +19.1% |
| Q3 2019 | $655,000 | +4.0% | 15,371 | -2.4% | 0.18% | +1.7% |
| Q2 2019 | $630,000 | +2.8% | 15,756 | +6.1% | 0.18% | -37.3% |
| Q1 2019 | $613,000 | – | 14,845 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |